RPRX

Royalty Pharma plc Class A Ordinary Shares

67.64

USD

+0.34

+0.51%

Nov 09, 09:51 UTC -5

Open

Royalty Pharma plc Class A Ordinary Shares (RPRX) Profile

Royalty Pharma plc Class A Ordinary Shares Profile

About

Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko and Trikafta, and development-stage product candidates. Royalty Pharma plc is based in NEW YORK.

Info & Links

CEO

Pablo Legorreta

Headquarters

110 East 59th Street
New York, NY 10022, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

100

Royalty Pharma plc Class A Ordinary Shares Statistics

Valuation Measures

Market Capitalization²

30.12B

Enterprise Value

38.19B

Enterprise Value/EBITDA(ttm)

24.94

Price to Earnings Ratio(ttm)

12.72

Price to Sales(ttm)

14.79

Price to Book(mrq)

3.95

Price to Cash(ytd)

14.09

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

112.57%

Profit Margin(ttm)

26.24%

Return on Equity(ttm)

30.04%

Return on Invested Capital(ttm)

6.46%

Return on Assets(ttm)

14.97%

Income Statement

Revenue(ttm)

2.62B

Revenue Per Share(ttm)

4.56

Gross Profit(ttm)

2.62B

EBITDA(ttm)³

1.53B

Net Income Available to Common(ttm)

672.45M

Diluted EPS(ttm)

1.20

Share Statistics

Beta (5Y Monthly)

0.36

52-Week Change

75.41%

S&P 500 52-Week Change

14.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

573.61M

Dividend Yield

1.40%

Float⁴

466.67M

% Held by Insiders

18.84%

% Held by Institutions

54.35%

Balance Sheet

Total Cash(mrq)

544.86M

Total Cash Per Share(mrq)

0.95

Total Debt(mrq)

8.59B

Total Debt/Equity(mrq)

87.67%

Current Ratio(mrq)

1.29%

Quick Ratio(mrq)

1.29%

Book Value Per Share(mrq)

9.74

Cash Flow

Operating Cash Flow Per Share(ytd)

3.83

Free Cash Flow(ytd)

1.15B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.